UK Drug Discovery Funding Rounds 2023

Every UK Drug Discovery funding round filed in 2023, sourced direct from Companies House filings. Updated weekly.

UK Drug Discovery Funding Rounds 2023

CompanyRaisedRoundDate
Eligochem£33k-2025/05/27
Celadon Pharmaceuticals£2.0M-2024/02/27
Eliem Therapeutics (Uk)£2.6M-2024/02/19
My-T Bio£899kSeries A2024/01/29
Proveca£5.1M-2024/01/20
Ellipses Pharma£8.6M-2024/01/05
Kaerus Bioscience£3.3MSeries A2024/01/03
Nodus Oncology£1.8M-2023/12/28
Carcinotech£4.3M-2023/12/28
Ignota Labs£290k-2023/12/28
Leucid Bio£53k-2023/12/22
Cumulus Oncology£9.0M-2023/12/21
Actimed Therapeutics£2.3M-2023/12/21
Oxford Vacmedix Uk£807k-2023/12/20
Valink Therapeutics£960k-2023/12/19
Rnavate£4.7M-2023/12/15
Epsilogen£5.0MSeries B2023/12/15
My Personal Therapeutics£16k-2023/12/12
Cytospire Therapeutics£7.0MSeed2023/12/06
Celadon Pharmaceuticals£1.0M-2023/12/03
Re-Vana Therapeutics£4.7MSeries A2023/12/01
Orfonyx Bio£2.0MSeed2023/12/01
Levicept£6.6MSeries B2023/11/30
Astellas Engineered Small Molecules U.K.£50k-2023/11/28
Medimab Biotherapeutics£300k-2023/11/27

Sign up to see all uk drug discovery funding rounds 2023

+77 more rounds

Sign up

More Drug Discovery funding